Sudden Arrhythmia Death Syndromes Foundation
In This Issue
Quick Poll
Upcoming Events
Ohio Family Seminar
FDA Alert: Drug Shortage
SADS Returns from NY!
Twitter Bird
Do you tweet?  We want to know! Take the latest SADS quick poll today.
Upcoming Events

Become part of the 16th annual "No Ball at All" campaign!

Ben Curtis Charity Golf Day in Australia- Mar 19, 2010

Benefit Concert From the Heart in Memphis, March 29

Medical Seminar: Understanding SCD in Children - Arizona - April 17, 2010

SADS Family Seminar in Cincinnati, OH - May 1, 2010

SADS Family and Medical Seminar at New York University -June 5, 2010--More info coming soon!

To add to your special fund-raising event please contact Laura or call 800-783-7723

Meet your local contact today!
Join Our Mailing List
Join our cause

Facebook logo


Follow us now
Twitter logo

Here's the latest news from the SADS Foundation.  Please take a moment and catch up on the most recent happenings.
SADS Family Seminar--next stop Cincinnati, Ohio!

When: Saturday May 1, 2010
           8:30 AM to 12 PM

Where: Cincinnati Children's Hospital
      Fifth Third Bank Auditorium

Cost: FREE!
Jeffrey Towbin, M.D.
Directory of Cardiology, Cincinnati Children's Hospital
Co-Director Heart Institute, Cincinnati Children's Hospital

Timothy Knilans, M.D.
Director, Clinical Cardiac Electrophysiology & Pacing Heart Institute
Cincinnati Children's Hospital

Erin M. Miller, M.S. CGC
Genetic Counselor
Heart Institute
Cincinnati Children's Hospital

For more information about this event, or to register, please contact Joanne or call 1-800-STOP-SAD (800-786-7723)
FDA Alert: Invirase (Saquinavir ) and Norvir (Ritonavir)
The U.S. Food and Drug Administration (FDA) is reviewing clinical trial data about a potentially serious effect on the heart from the use of Invirase (saquinavir) in combination with Norvir (ritonavir).  The data suggest that together the two drugs may affect the QT interval of the heart.  A prolonged QT interval can increase the risk for abnormal heart rhythms, including a serious abnormal rhythm called torsades de pointes. 

The FDA's analysis of these data is ongoing.  Patients concerned about possible risks associated with using Invirase and Norvir should continue to take their prescribed medication and  talk to their healthcare professional. 

Click here to read the FDA press release.

Click here to see the NEW list of Drugs to Avoid in Brugada Syndrome. For information about the Mexiletine drug shortage, click here.
SADS Returns from New York!
One of the highlights of the NY trip is that we secured the National Chairpeople for the 4th annual Climb to Conquer SADS. Anthony and Cathy Lucatuorto have graciously accepted this job, and are busy matching climbers and families. 

Climb to Conquer SADS
For anyone who would like to be part of this exciting event, they can e-mail Anthony Lucatuorto at or Laura.

For more information on the Climb to Conquer SADS, please visit our website.

Alice, Laura, Joanne, Heidi and Adrienne

SADS Foundation
508 East South Temple, Suite 202
Salt Lake City, UT  84102